CG Oncology, Inc.
CGON
$64.25
-$0.20-0.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -161.00M | -151.48M | -128.08M | -105.56M | -88.04M |
| Total Depreciation and Amortization | 1.45M | 596.00K | 201.00K | 52.00K | 32.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.93M | 22.94M | 16.63M | 11.76M | 6.39M |
| Change in Net Operating Assets | 2.28M | 11.16M | 17.43M | 11.77M | 2.91M |
| Cash from Operations | -132.35M | -116.79M | -93.82M | -81.98M | -78.71M |
| Capital Expenditure | -134.00K | -336.00K | -238.00K | -238.00K | -234.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -21.97M | -21.97M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -223.72M | -137.11M | -142.21M | -179.85M | -300.53M |
| Cash from Investing | -245.82M | -159.41M | -142.45M | -180.09M | -300.76M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -365.00K |
| Issuance of Common Stock | 153.91M | 278.22M | 226.28M | 226.34M | 632.07M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -316.00K | -277.00K | -547.00K | -269.00K | -3.42M |
| Cash from Financing | 153.59M | 277.94M | 225.74M | 226.07M | 628.28M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -224.58M | 1.73M | -10.53M | -36.00M | 248.80M |